Recombinants within the Tyrosine Kinase Region of v-abl and v-src Identify a v-abl Segment That Confers Lymphoid Specificity

Literature Cited

• Brugge, J., and D. Darrow. 1984. Analysis of the catalytic domain of the phosphotransferase activity of two avian sarcoma virus transforming proteins. J. Biol. Chem. 259:4550-4557.
   PubMedGoogle Scholar
• Brugge, J. S., E. Erikson, and R. L. Erikson. 1981. The specific interaction of the Rous sarcoma virus transforming protein, pp60v-src, with two cellular proteins. Cell 25:363-372.
   PubMed Web of Science ®Google Scholar
• Brugge, J. S., W. Yonemoto, and D. Darrow. 1983. Interaction between the Rous sarcoma virus transforming protein and two cellular phosphoproteins: analysis of the turnover and distribution of this complex. Mol. Cell. Biol. 3:9-19.
   PubMed Web of Science ®Google Scholar
• Buss, J. E., M. P. Kamps, and B. M. Sefton. 1984. Myristic acid is attached to the transforming protein of Rous sarcoma virus during or immediately after synthesis and is present in both soluble and membrane-bound forms of the protein. Mol. Cell. Biol. 4:2697-2704.
   PubMed Web of Science ®Google Scholar
• Cook, W. D., D. Metcalf, N. A. Nicola, A. W. Burgess, and F. Walker. 1985. Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism. Cell 41:677-683.
   PubMed Web of Science ®Google Scholar
• Courtneidge, S. A., and J. M. Bishop. 1982. Transit of pp60v-src to the plasma membrane. Proc. Natl. Acad. Sci. USA 79:7117-7121.
   PubMed Web of Science ®Google Scholar
• Cross, F. R., E. A. Garber, and H. Hanafusa. 1985. N-terminal deletions in Rous sarcoma virus p60src: effects on tyrosine kinase and biological activities and on recombination in tissue culture with the cellular src gene. Mol. Cell. Biol. 5:2789-2795.
   PubMedGoogle Scholar
• DePinho, R., K. Kruger, N. C. Andrews, S. Lutzger, D. Baltimore, and F. W. Alt. 1984. The molecular basis of heavy-chain class switching and switch region deletion in an Abelson virus-transformed cell line. Mol. Cell. Biol. 4:2905-2910.
   PubMedGoogle Scholar
• Garber, E. A., B. J. Mayer, R. Jove, and H. Hanafusa. 1987. Analysis of p60v-src mutants carrying lesions involved in temperature sensitivity. J. Virol. 61:354-360.
   PubMedGoogle Scholar
• Hanafusa, H. 1977. Cell transformation by RNA tumor viruses, p. 401-483. In H. Fraenkel-Conrat and R. R. Wagner (ed.), Comprehensive virology, vol. 10. Plenum Publishing Corp., New York.
   Google Scholar
• Hunter, T., and J. A. Cooper. 1985. Protein-tyrosine kinases. Annu. Rev. Biochem. 54:897-930.
   PubMed Web of Science ®Google Scholar
• Kamps, M. P., S. S. Taylor, and B. M. Sefton. 1984. Direct evidence that oncogenic tyrosine kinases and cyclic AMP-dependent protein kinase have homologous ATP-binding sites. Nature (London) 310:589-592.
   PubMed Web of Science ®Google Scholar
• Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
   PubMed Web of Science ®Google Scholar
• Leoff, E. B., J. J. Van Wyke, E. J. O’Keefe, and W. J. Pledger. 1983. EGF is required only during the traverse of early G1 in PDGF stimulated density arrested BALB/c-3T3. Exp. Cell. Res. 147:202-208.
   PubMedGoogle Scholar
• Lipsich, L. A., A. J. Lewis, and J. S. Brugge. 1983. Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses. J. Virol. 48:352-360.
   PubMedGoogle Scholar
• Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Mathey-Prevot, B., and D. Baltimore. 1985. Specific transforming potential of oncogenes encoding protein-tyrosine kinases. EMBO J. 4:1769-1774.
   PubMedGoogle Scholar
• Mathey-Prevot, B., H. Hanafusa, and S. Kawai. 1982. A cellular protein is immunologically crossreactive and functionally homologous to the Fujinami sarcoma virus transforming protein. Cell 28:897-906.
   PubMed Web of Science ®Google Scholar
• Mathey-Prevot, B., G. Nabel, R. Palacios, and D. Baltimore. 1986. Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line. Mol. Cell. Biol. 6:4133-4135.
   PubMed Web of Science ®Google Scholar
• Murtagh, K., G. Skladany, J. Hoag, and N. Rosenberg. 1986. Abelson murine leukemia virus variants with increased oncogenic potential. J. Virol. 60:599-606.
   PubMedGoogle Scholar
• Oliff, A., O. Agranovsky, M. D. McKinney, V. V. V. S. Murty, and R. Bauchwitz. 1985. Friend murine leukemia virus-immortalized myeloid cells are converted into tumorigenic cell lines by Abelson leukemia virus. Proc. Natl. Acad. Sci. USA 82:3306-3310.
   PubMedGoogle Scholar
• Pierce, J. H., S. A. Aaronson, and S. M. Anderson. 1984. Hematopoietic cell transformation by a murine recombinant retrovirus containing the src gene of Rous sarcoma virus. Proc. Natl. Acad. Sci. USA 81:2374-2378.
   PubMed Web of Science ®Google Scholar
• Pierce, J. H., P. P. Di Fiore, S. A. Aaronson, M. Potter, J. Pumphrey, A. Scott, and J. H. Ihle. 1985. Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism. Cell 41:685-693.
   PubMed Web of Science ®Google Scholar
• Privalsky, M. L. 1987. Analysis of the biochemical and biological properties of a v-erbB/src fusion polypeptide. J. Virol. 61:1938-1948.
   PubMedGoogle Scholar
• Prywes, R., J. Hoag, N. Rosenberg, and D. Baltimore. 1985. Protein stabilization explains the gag requirement for transformation of lymphoid cells by Abelson murine leukemia virus. J. Virol. 54:123-132.
   PubMedGoogle Scholar
• Reddy, E. P., M. J. Smith, and A. Srinivasan. 1983. Nucleotide sequence of Abelson murine leukemia virus genome: structure similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity. Proc. Natl. Acad. Sci. USA 80:3625-3629.
   Google Scholar
• Rosenberg, N., D. Baltimore, and C. D. Scher. 1975. In vitro transformation of lymphoid cells by Abelson murine leukemia virus. Proc. Natl. Acad. Sci. USA 72:1932-1936.
   PubMedGoogle Scholar
• Rosenberg, N., D. R. Clark, and O. N. Witte. 1980. Abelson murine leukemia virus mutants deficient in kinase activity and lymphoid cell transformation. J. Virol. 36:766-774.
   PubMedGoogle Scholar
• Scher, C. D., and R. Siegler. 1975. Direct transformation of 3T3 cells by Abelson murine leukemia virus. Nature (London) 253:729-731.
   PubMed Web of Science ®Google Scholar
• Schwartz, D. E., R. Tizard, and W. Gilbert. 1983. Nucleotide sequence of Rous sarcoma virus. Cell 32:853-869.
   PubMed Web of Science ®Google Scholar
• Southern, P. J., and P. Berg. 1982. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:327-342.
   PubMedGoogle Scholar
• Takeya, T., and H. Hanafusa. 1982. Structure and sequence of the viral and cellular src gene of chickens. I. Complete nucleotide sequence of an EcoRI fragment of recovered avian sarcoma virus which codes for gp37 and pp60src. J. Virol. 44:1-11.
   PubMedGoogle Scholar
• Wang, J. Y. J. 1985. Isolation of antibodies for phosphotyrosine by immunization with a v-abl oncogene-encoded protein. Mol. Cell. Biol. 5:3640-3643.
   PubMedGoogle Scholar
• Wang, J. Y. J., and D. Baltimore. 1985. Localization of tyrosine kinase-coding region in v-abl oncogene by the expression of v-abl-encoded proteins in bacteria. J. Biol. Chem. 260:64-71.
   PubMed Web of Science ®Google Scholar
• Watanabe, S. M., N. Rosenberg, and O. N. Witte. 1984. A membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitro. J. Virol. 51:620-627.
   PubMedGoogle Scholar
• Ziegler, S. F., C. A. Whitiock, S. P. Goff, A. Gifford, and O. N. Witte. 1981. Lethal effect of the Abelson murine leukemia virus transforming gene product. Cell 27:477-486.
   PubMedGoogle Scholar
• Zoller, M. J., and M. Smith. 1984. Oligonucleotide-directed mutagenesis: a simple method using two oligonucleotide primers and a single-stranded DNA template. DNA 3:479-488.
   PubMedGoogle Scholar